According to the enterprise research app, recently, Tianjin Huada Gibai Biotechnology Co., Ltd. was established. Its business scope includes Class III medical device management; Class II medical device production; inspection and testing services; and Class III medical device production. The company's equity penetration revealed that the company is wholly owned by BGI.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.